Cocrystal Pharma (COCP)

• Market cap: $14.1M
• 1 day: -2.93%
• 5 days: -6.59%
• 1 month: -9.17%
• 3 months: -35.29%
• 6 months: -29.78%
• Year to date: -57.32%
• 1 year: -51.94%
• 5 years: -90.73%
• 10 years: -98.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Employees: 11